BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37667251)

  • 21. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MIR503HG promotes esophageal squamous cell carcinoma cell proliferation, invasion and migration via hsa-miR-503 pathway].
    Gong TY; Chen HY; Liu ZH
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1160-1167. PubMed ID: 36380664
    [No Abstract]   [Full Text] [Related]  

  • 23. lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis.
    Pan C; Chen G; Zhao X; Xu X; Liu J
    Eur J Pharmacol; 2022 Nov; 934():175317. PubMed ID: 36216119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis.
    Chen S; Liu Z; Feng Q; Zhou J; Huang J; Yu J
    Anticancer Drugs; 2023 Feb; 34(2):195-206. PubMed ID: 36206112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
    Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA circ-PRKCI functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-3680-3p in esophageal squamous cell carcinoma.
    Shi N; Shan B; Gu B; Song Y; Chu H; Qian L
    J Cell Biochem; 2019 Jun; 120(6):10021-10030. PubMed ID: 30659640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0023984 Facilitates Esophageal Squamous Cell Carcinoma Progression by Regulating miR-433-3p/REV3L Axis.
    Li T; Li S
    Dig Dis Sci; 2022 Mar; 67(3):892-903. PubMed ID: 33725240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
    Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
    J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA circ-TNRC6B inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by regulating the miR-452-5p/DAG1 axis.
    Xu R; Ding P; Zhao X; Li Z; Liu F; Gu L; Zheng Y; Sang M; Meng L
    Mol Oncol; 2023 Jul; 17(7):1437-1452. PubMed ID: 37014625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA circNELL2 Acts as the Sponge of miR-127-5p to Promote Esophageal Squamous Cell Carcinoma Progression.
    Xiong G; Diao D; Lu D; Liu X; Liu Z; Mai S; Feng S; Dong X; Cai K
    Onco Targets Ther; 2020; 13():9245-9255. PubMed ID: 32982311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-671-5p sponging activity of circMMP1 promotes esophageal squamous cancer progression.
    Li R; Chai L; Lei L; Guo R; Wen X
    Thorac Cancer; 2023 Oct; 14(29):2924-2933. PubMed ID: 37635445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of hsa_circ_0000977 participates in esophageal squamous cancer progression by sponging miR-874-3p.
    Li N; Wu J; Hu B; Lu H; Gao J; Zhu L; Zheng D
    J Clin Lab Anal; 2022 Jun; 36(6):e24458. PubMed ID: 35476874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.
    He Z; Yi J; Liu X; Chen J; Han S; Jin L; Chen L; Song H
    Mol Cancer; 2016 Jun; 15(1):51. PubMed ID: 27358073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LINC00473/miR-374a-5p regulates esophageal squamous cell carcinoma via targeting SPIN1 to weaken the effect of radiotherapy.
    Chen W; Zhang Y; Wang H; Pan T; Zhang Y; Li C
    J Cell Biochem; 2019 Sep; 120(9):14562-14572. PubMed ID: 31017716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.
    Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
    Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circ_0008726 promotes malignant progression of ESCC cells through miR-206/HOXA13 pathway.
    Han T; Shi M; Chen G; Hao J
    Gen Thorac Cardiovasc Surg; 2023 Jan; 71(1):33-45. PubMed ID: 36190650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00324 promotes cell proliferation and metastasis of esophageal squamous cell carcinoma through sponging miR-493-5p via MAPK signaling pathway.
    Sharma U; Kaur Rana M; Singh K; Jain A
    Biochem Pharmacol; 2023 Jan; 207():115372. PubMed ID: 36493845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma.
    Fang XY; Sun JJ; Chen SY; Wu KJ; Yu Y; Zhang C; Duan CZ
    Ann Clin Lab Sci; 2021 May; 51(3):329-338. PubMed ID: 34162562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-204-5p inhibits cell proliferation and induces cell apoptosis in esophageal squamous cell carcinoma by regulating Nestin.
    Luo H; Lv W; Zhang H; Lin C; Li F; Zheng F; Zhong B
    Int J Med Sci; 2022; 19(3):472-483. PubMed ID: 35370458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.